Compare Bath & Body Works Inc (BBWI) vs Centene Corp (CNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bath & Body Works Inc vs Centene Corp — how do they compare? Bath & Body Works Inc trades at $18.9 (market cap $3.89B), while Centene Corp trades at $66.33 (market cap $32.89B). The key difference: Centene Corp is far larger — about 8.5× Bath & Body Works Inc's market cap, and Bath & Body Works Inc pays a 4.14% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| BBWI | CNC | |
|---|---|---|
Market Cap | $3.89B | $32.89B |
Sector | Consumer Cyclical | Health |
52-Week High | $31.87 | $68.72 |
52-Week Low | $14.85 | $26.17 |
Enterprise Value | $7.79B | $21.93B |
Dividend Yield | 4.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bath & Body Works Inc
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with less than 5% of sales from international markets in fiscal 2021. For fiscal 2021, 72% of sales stemmed from the brick-and-mortar network (which is composed of more than 1,700 retail stores), up from 65% in 2020, as consumer shopping patterns began to return to normal. Future growth is expected from store reformatting, digital and international channels, as well as new category expansion.
Read more on BBWI →About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →
